The risk of type 2 diabetes mellitus in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study
Eun Bin Cho(Changwon National University), Ju‐Hong Min(Samsung Medical Center), Soonwook Kwon(Inha University Hospital), Dong Wook Shin(Samsung (South Korea)), Sang‐Man Jin(Samsung Medical Center), Jin‐Hyung Jung(Samsung (South Korea)), Junhee Park(Samsung Medical Center), Kyungdo Han(Catholic University of Korea), Yeon Hak Chung(Samsung Medical Center)
Cited by 8
Related Papers
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
|Diabetes & Metabolism Journal|2023|123
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
|Diabetes & Metabolism Journal|2024|69